Clinical Trial Update: Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study [Phase 4]

View source ↗

Summary

Phase 4 pharmacodynamic study comparing ticagrelor and prasugrel in diabetic patients with coronary artery disease/acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Patras | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED